ImmunityBio (IBRX) Non Operating Investment Income (2015 - 2026)
ImmunityBio (IBRX) reported Non Operating Investment Income of $3.16 million for Q2 2026, up 173.6% from $1.15 million a year earlier and up 36.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Non Operating Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ImmunityBio's Non Operating Investment Income came in at $9.83 million, up 95.7% year-over-year; for FY2025, it came in at $6.41 million, down 19.7% from FY2024.
- Non Operating Investment Income has a five-year compound annual growth rate of 21.3% (FY2020 to FY2025).
- By year, Non Operating Investment Income came in at $7.98 million in FY2024 (+605.1%), $1.13 million in FY2023, -$3.09 million in FY2022 and -$4.1 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Investment Income since Q1 2021.
- Year over year, Non Operating Investment Income has now increased in each of the last four quarters, with growth averaging 68.3% over the last seven quarters.
- The high point for year-over-year Non Operating Investment Income in five years was Q1 2024 (growth of 360.5%); the low point was Q3 2023 (a decline of 95.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.31 million (Q1 2026), $2.3 million (Q4 2025) and $2.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn | 3.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 887,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 484,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | -61,000.00 |
| Mar 31, 2023 | 673,000.00 |
| Dec 31, 2022 | -3.81 Mn |
| Sep 30, 2022 | 857,000.00 |
| Jun 30, 2022 | -1.80 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | -6.93 Mn |
| Sep 30, 2021 | -5.94 Mn |
API Access
ImmunityBio Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();